Global Animal Gelatin Capsule Market Overview:
Gelatin is made through a process that involves boiling certain parts of the cattle like the hoofs, bones and connective tissue until it gives the gel-like substance. The gelatin is a tasteless, odorless and colorless substance that can be formed into the gelatin capsules which are taken by consumers. These capsules do have a wide range of health benefits which improves skin and joint health but not forgetting the side effects associated with it. They are also less expensive compared to vegetarian capsules.
Market Drivers
- Increasing Need for Aging Skin Treatment
- Rising Demand of Capsules for Joint Pain Treatment
Market Trend
- Continuous Research and Development in Pharmaceutical Products
- Increasing use of Gelatin Capsules in Cosmetic Products
Restraints
- Shifting Preferences Towards Vegetarian Capsules
- Side Effects Associated with Animal Gelatin Capsules
- Stringent Regulatory Guidelines
Opportunities
- Increasing Investment in Healthcare and Pharmaceutical Infrastructure
- Improving Packaging and Labelling of Animal Gelatin Capsules
Challenges
- Lack of Quality of the Animal Gelatin Capsules
- Problems with Packaging and Labelling of Animal Gelatin Capsules
Competitive Landscape:
Some of the key players profiled in the report are Capsugel (United States), EuroCaps Ltd. (United Kingdom), ACG World (India), Makers Nutrition LLC (United States), Superior Supplement Manufacturing (United States), Gemini Pharmaceuticals, Inc. (United States), Atlantic Essential Products Inc. (United States), LiquidCapsule Manufacturing, LLC (United States), Ceba-Tek, Inc. (United States) and Saviour Caps Pvt. Ltd (India). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Animal Gelatin Capsule market by 2024. Considering Market by Origin, the sub-segment i.e. Bovine will boost the Animal Gelatin Capsule market. Considering Market by Filling Form, the sub-segment i.e. Powder Filled will boost the Animal Gelatin Capsule market.
"The Central Drugs Standard Control Organisation (CDSCO) under the Ministry of Health and Family Welfare has constituted an expert committee to address all the technical issues pertaining to replacing gelatin with cellulose for encapsulating drugs. According to a BIS document, vegetable capsules might soon replace the usage of gelatin capsules. Modified naturally-occurring polymer cellulose is considered safe for normal consumption in humans. Hydroxypropyl methylcellulose (HPMC), most commonly known as hypromellose, is mainly used for manufacturing such capsule shells."
Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Animal Gelatin Capsule market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Animal Gelatin Capsule market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Animal Gelatin Capsule Manufacturers, Animal Gelatin Capsule International Traders, Animal Gelatin Capsule Distributors and Suppliers, Research and Development Institutes, Potential Investors, Regulatory Bodies, Upstream and Downstream Buyers and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.